Form 8-K - Current report:
SEC Accession No. 0001558370-25-001950
Filing Date
2025-02-28
Accepted
2025-02-28 16:53:32
Documents
14
Period of Report
2025-02-24
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K gbio-20250224x8k.htm   iXBRL 8-K 36704
  Complete submission text file 0001558370-25-001950.txt   157763

Data Files

Seq Description Document Type Size
2 EX-101.SCH gbio-20250224.xsd EX-101.SCH 4038
3 EX-101.DEF gbio-20250224_def.xml EX-101.DEF 2738
4 EX-101.LAB gbio-20250224_lab.xml EX-101.LAB 13970
5 EX-101.PRE gbio-20250224_pre.xml EX-101.PRE 10836
16 EXTRACTED XBRL INSTANCE DOCUMENT gbio-20250224x8k_htm.xml XML 4660
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 857-529-5908
Generation Bio Co. (Filer) CIK: 0001733294 (see all company filings)

EIN.: 814301281 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39319 | Film No.: 25691585
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)